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1 Xiaojun Liu and Aijun Qiao contributed equally toRecent studies have demonstrated that FoxO1 modulates the expression of SREBP-1c, but the exact
mechanism remains unknown. Our results demonstrate that FoxO1 suppresses the SREBP-1c pro-
moter transcriptional activity in HepG2 cells. This repression was independent of FoxO1 binding
to the SREBP-1c promoter, but LXR responsive elements (LXREs) were crucial to this phenomenon.
Moreover, FoxO1 also strongly inhibited the LXRa-mediated elevated transcription by SREBP-1c pro-
moter. Electrophoretic mobility shift assay and chromatin immuno-precipitation further suggested
the ability of FoxO1 to inhibit LXRa binding with the LXRE in the SREBP-c promoter. FoxO1-medi-
ated suppression of SREBP-1c promoter activity could be partially alleviated by insulin.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction highly conserved residues (corresponding to Thr-24, Ser-256 andSREBP-1c is a transcription factor involving in fatty acid synthe-
sis in differentiated tissues and organs. In addition, SREBP-1c also
appears to be a mediator of insulin/glucose signaling to lipogene-
sis, and is linked with the insulin resistance, remnant lipoprotein
and fatty livers [1].
Forkhead box-‘‘Other” (FoxO) transcription factors critically
control fundamental cellular processes, including metabolism, cell
differentiation and other reactions to cellular stress. FoxO tran-
scription factors bind as monomers to a consensus DNA-binding
sequence, TTGTTTAC [2]. In the absence of any cellular stimulus,
FoxOs are localized in the nucleus, where they regulate transcrip-
tion of their target genes. Upon activation of protein kinase B (PKB)
by growth or survival factors, FoxOs are phosphorylated at theirchemical Societies. Published by E
binding proteins; FoxO, fork-
a, peroxisome proliferator-
liver X receptor; FASN, fatty
4-type, direct repeat 4 type;
isome proliferator-activated
bility shift assay; ChIP, chro-
A, relative luciferase activity
ang), fangfd@vip.sina.com (F.
this work.Ser-319 in human FoxO1), relocalizing from the nucleus to the
cytosol, and no longer function as transcriptional activators [3].
Consequently, insulin can activate PKB and attenuate FoxO-medi-
ated expression of regulated proteins.
FoxO1 has been demonstrated to have the dual role in control-
ling hepatic insulin sensitivity and lipid metabolism. In conditions
of impaired insulin signaling, FoxO1 activity increases, leading to
excessive glucose production. At the same time, it increases Akt
signaling and suppresses Peroxisome proliferator-activated recep-
tor-a expression, leading to increased TG synthesis through SREBP-
1 and decreased fatty acid oxidation [4]. In contrast, gene-array
studies demonstrated that FoxO1 modulates the expression of
multiple genes involved in glucose metabolism and lipogenesis
in vivo, including glucokinase and SREBP-1c [5]. Recently, Kamei’s
study indicated that retinoid X receptor (RXR)/liver X receptor
(LXR) up-regulated SREBP1c gene expression, and that FoxO1
antagonized this effect of RXR/LXR in skeletal muscle [6].
This study further investigated the modulatory effect of FoxO1
on mouse SREBP-1c promoter in HepG2 cells, by which FoxO1
inhibits the transcription of SREBP-1c.2. Materials and methods
Materials and methods are shown as Supplementary material.lsevier B.V. All rights reserved.
Fig. 2. Repression of mSREBP-1c promoter activity by over-expression of FoxO1.
HepG2 cells were co-transfected with the luciferase reporter plasmids pBP1c2600-
Luc (200 ng) and equivalent amounts of plasmids expressing FoxO1-wt, FoxO1-3A,
FoxO1-3A(H215R) or control vectors. *P < 0.05.
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3.1. FoxO1 inhibits the promoter activity of mouse SREBP-1c
To study the effect of FoxO1 on SREBP-1c gene expression,
FoxO1-3A expression plasmids were transfected into HepG2 cells.
FoxO1-3A is a constitutive activity mutant of three principal Akt-
catalyzed phosphorylation sites are substituted by alanine confer-
ring it resistance to growth factor-induced phosphorylation and
inactivation by nuclear exclusion [3]. Over-expression of FoxO1-
3A down-regulates the expression of SREBP-1c and its target gene,
fatty acid synthase (FASN), but not SREBP-1a (Fig. 1).
To investigate the molecular mechanism of FoxO1-inﬂicted sup-
pression of SREBP-1c, promoter-luciferase construct, pBP1c2600-
Luc, was co-transfected in HepG2 cells with plasmids expressing
wild-type of FoxO1(FoxO1-wt), or mutants (FoxO1-3A or FoxO1-
3A(H215R)), respectively. All of three forms of FoxO1 evidently de-
creased the reporter gene transcription driven by SREBP-1c pro-
moter (Fig. 2). FoxO1-3A(H215R), a mutant whose His-215
residue has been replaced by arginine markedly impairing its
DNA binding [7], inhibiting the SREBP-1c promoter activity sug-
gests that the down-modulation of SREBP-1c promoter by FoxO1
does not require its physical binding to the DNA. As control,
FoxO1-wt and FoxO1-3A enhanced the transcription activity of
3IRES-promoter, but not FoxO1-3A(H215R) (Fig. S1).
3.2. LXR elements are crucial for FoxO1-inﬂicted inhibition of mSREBP-
1c promoter
To elucidate the mode of FoxO1-suppression of the SREBP-1c
promoter, we designed 50-deletion experiments constructing mul-
tiple reporters with varying segments of the promoter. Luciferase
reporter inhibition by ectopically expressed FoxO1 was estimatedFig. 1. FoxO1 down-regulates the expression of SREBP-1c and its target gene. HepG2 ce
proteins were extracted and total RNA was isolated. (A) The protein level of SREBP-1, Fla
SREBP-1a, 1c, FoxO1, and FASN was determined by real-time PCR and normalized to GAfor all samples and normalized using pBP1c500-Luc and empty
vector as the reference. In HepG2 cells harboring pBP1c500-Luc
and pBP1c250-Luc constructs, FoxO1-3A-mediated inhibition of
luciferase expression ranged from 6.4 to 4.7 fold, respectively. This
FoxO1-repression of the luciferase activity reduced to only twofold
in assays using pBP1c148-Luc. Likewise, no repression of the repor-
ter gene that was governed by 94 bp region of promoter was ob-
served in HepG2 cells (Fig. 3).
3.3. FoxO1 suppresses LXRa-mediated activation of mSREBP-1c
promoter activity
By analysis the promoter of SREBP-1c, there are two LXR
responsive elements (LXREs) between 250 and 148 bp. Wells were transfected with pcDNA3-Flag-FoxO1-3A or control vector. 48 h later, total
g-FoxO1-3A and actin was determined by Western blotting. (B) The mRNA level of
PDH level.*P < 0.05, **P < 0.01.
Fig. 3. FoxO1-mediated repression of luciferase expression driven by mSREBP-1c
promoter. HepG2 cells were co-transfected with a luciferase reporter gene under
the control of varying promoter segments of mSREBP-1c along with the FoxO1-3A
expression construct or empty vector. *P < 0.05, **P < 0.01.
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mediated repression of SREBP-1c promoter activity. LXRs are
members of the nuclear receptor superfamily that are activated
by oxysterols and other metabolic intermediates of cholesterol
pathway. LXRs form heterodimers with RXR and bind to their tar-
get DNA consisting of direct repeat 4 type sequence motifs termed
as LXR responsive elements (LXREs) [8]. Previous studies have
shown that binding of LXRa to LXREs promotes the transcription
of SREBP-1c gene [9,10].
Functional analysis of the SREBP-1c promoter demonstrated the
involvement of LXREa and LXREb (250 to 148 bp) in the inhib-
itory action of FoxO1 (Fig. 3). To assess if FoxO1 would suppress
the activity of SREBP-1c promoter through LXRa, we utilized its
agonist TO901317 that is known to stimulate the SREBP-1c pro-
moter [8,11]. Our results revealed that over-expression of FoxO1-Fig. 4. FoxO1 Suppresses LXRa-mediated mSREBP-1c promoter transcription activity. (A)
cells were co-transfected with pBP1c2600-Luc reporter along with FoxO1-3A or contro
control) 24 h post-transfection. (B) Repression of LXRa-mediated mSREBP-1c promoter b
constructs (200 ng) together with the equivalent amounts of FoxO1-3A or control vecto
elements in SREBP-1c promoter. HepG2 (left panel) or 293A cells (right panel) were co
constructs together with equivalent amounts of FoxO1-3A or control plasmids. *P < 0.053A in HepG2 inhibited TO901317-induced SREBP-1c promoter
activity (Fig. 4A). To further validate the involvement of LXRa in
the mentioned phenomenon, we over-expressed LXRa together
with FoxO1-3A in HepG2 cells. The results demonstrated that all
versions of FoxO1 protein were able to inhibit the LXRa-mediated
activation of SREBP-1c promoter (Fig. 4B). Similarly, FoxO1 also
inhibited the mouse LXRb-mediated activation of SREBP-1c pro-
moter (Fig. S2).
In addition, we also performed luciferase assay using a construct
containing two LXREs (pE-LXRE-Luc). As shown in Fig. 4C, ectopic
over-expression of LXRa activates pE-LXRE-Luc activity in HepG2
as well as in 293A cells. This effect was alleviated by co-transfected
FoxO1-3A in 293A cells. However, FoxO1-3A did not inhibit pE-
LXRE-Luc activity in the absence of LXRa expression plasmid, which
may be due to low expression level of endogenous LXRa in 293A
cells (data not shown). These data further consolidated our notion
that FoxO1-inﬂicted suppression of SREBP-1c promoter is depen-
dent on LXRa. Interestingly, the ectopic expression of LXRa in
HepG2 cells only moderately stimulated the pE-LXRE-Luc. How-
ever, FoxO1-inhibition of its activity was more prominent in 293A
cells. This is probably because the endogenous expression level of
LXRa is higher in HepG2 cells, and this level of cellular LXRa is suf-
ﬁcient to maximally stimulate the activity of pE-LXRE-Luc.
To further conﬁrm the mentioned interactions in LXRa, LXRE
and FoxO1, we generated p500-LXREsmut-Luc mutant as previous
study [12] and pBP1c500mut-Luc mutant lacking both LXREs. In
contrast to pBP1c500-Luc, the reporter activity encoded by p500-
LXREsmut-Luc and pBP1c500mut-Luc could not be activated by
over-expression of LXRa. However, FoxO1-3A was still competent
in inhibiting SREBP-1c promoter in LXREs mutant as revealed by
our 50-deletion experiments (Fig. S3). The data indicate that theInhibition of TO901317-stimulated mSREBP-1c promoter activity by FoxO1. HepG2
l plasmids (300 ng each) and were treated with TO901317 (3 lM) or DMSO (as a
y FoxO1. HepG2 cells were co-transfected with pBP1c2600-Luc (200 ng) and LXRa
rs. (C) FoxO1-inﬂicted inhibition of LXRa-mediated transcriptional activity of LXRE
-transfected with 200 ng each of pE-LXRE-Luc reporter gene and LXRa expression
, **P < 0.01.
Fig. 5. FoxO1 inhibits LXRa-RXRa binding to LXREb of the SREBP-1c promoter
in vitro and in vivo. (A) EMSA was performed using protein extract from HepG2
cells. Lane 1, DNA probe only; Lane 2, DNA probe incubated with the protein extract
from HepG2 cells transfected with LXRa and RXRa expression vector for 48 h; Lane
3, same as lane 2, but with a 300-fold excess of unlabelled DNA probe; Lane 4, DNA
probe incubated with the protein extract from HepG2 cells transfected with LXRa,
RXRa and FoxO1-3A expression plasmids for 48 h; Lane 5, DNA probe incubated
with the protein extract from HepG2 cells transfected with LXRa, RXRa and FoxO1-
3A(H215R) expression plasmids for 48 h. (B) ChIP assay. CHO cells were transfected
with FoxO1-3A or control plasmids for 48 h. Protein-DNA complexes were immuno-
precipitated with anti-LXRa or control IgG antibody. SREBP-1c promoter region
harboring the LXRE site (249/+42) were ampliﬁed by PCR.
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only on the LXREs but also on the other unknown elements, which
require further investigation. By analysis the promoter of SREBP-
1c, there is a SRE complex at 90 bp and is essential to the basal
promoter activity and confers responsiveness to activation by nu-
clear sterol regulatory element binding proteins (SREBPs) [13]. It
is supposed that the luciferase activity of mouse SREBP-1c pro-
moter was inhibited by over-expression FoxO1 down-regulation
the endogenous SREBP-1c protein expression.
Most LXR proteins are typically localized in the nucleus and re-
quire hetero-dimerization with RXR for their function as the tran-
scriptional activator of SREBP-1c mRNA [10]. In our reporter assays
(Fig. S4), FoxO1 effectively alleviated RXRa- alone and RXRa/LXRa-
potentiated transcription of luciferase by mSREBP-1c promoter. In
addition, FoxO1 and LXRa can inter-antagonize the transcriptional
activity of mSREBP-1c promoter in a dose-dependent manner
(Fig. S5).
3.4. FoxO1 inhibits LXRa binding to the LXRE
FoxO transcription factors suppress gene expression by seques-
tering other transcription factors and/or co-activators, inducing the
expression of repressor proteins, and possibly by recruiting co-
repressor proteins to promoters [5]. To further investigate the
mechanism by which FoxO1 suppresses the LXRa-mediated activa-
tion of SREBP-1c promoter, electrophoretic mobility shift assay
(EMSA) and chromatin immuno-precipitation (ChIP) were per-
formed. For EMSA, our results showed that both of FoxO1-3A and
FoxO1-3A(H215R) inhibited the interaction of the synthetic dou-
ble-stranded oligonucleotides and LXRa/RXRa dimmer as sug-
gested by the intensity of the band in lane 4 and 5 is obviously
less than that in lane 2 (Fig. 5A). ChIP assays were performed with
chromatin isolated from the CHO cells transfected with FoxO1-3A
and control plasmids. As shown in Fig. 5B, our results suggested
that FoxO1 inhibits endogenous LXRa binding to SREBP-1c pro-
moter region harboring LXRE. These results consolidated our ﬁnd-
ings that FoxO1-inﬂicted suppression of the SREBP-1c promoter is
dependent on the binding of LXRa to the LXR elements.
Since FoxO1 can repress LXRa binding to LXRE, we investigated
if FoxO1 is able to interact with LXRa and impair its function. Our
results using Co-IP and mammalian two-hybrid system con-
tradicted this notion (data not shown). In addition, we found that
wild-type FoxO1 as well as FoxO1-3A mutant, but not FoxO1-
3A(H215R) mutant, are moderately capable of repressing the pro-
moter activity of LXRa in HepG2 cells (Fig. S6). However, akin to
FoxO1-3A and FoxO1-3A(H215R) are equally competent in
repressing the SREBP-1c promoter. Hence, we conclude that the
inhibition of SREBP-1c promoter by FoxO1 is not because of the
FoxO1-inﬂicted down-regulation of LXRa transcription.
Previous studies had shown that FoxO1 can regulate gluconeo-
genesis or the expression of GK by interaction with Peroxisome
proliferator-activated receptor-c coactivator-1a (PGC-1a) [14].
Meanwhile, PGC-1a as a co-activator can activate the RXR-driven
transcription by interaction with RXR [15] and can induce the
LXR-mediated transcription [16]. Other factors such as small
heterodimer partner (SHP) involved in the regulation of gene tran-
scription interact not only with FoxO1, but also with LXRa [17–20].
This may implicate that FoxO1 disrupts the effect of LXRa through
other factors. The detailed mechanism(s) of FoxO1 action on
SREBP-1c promoter demands further investigation.
3.5. Effects of insulin on the repression of LXRa trans-activation by
FoxO1
Insulin is reported to rapidly induce the transcription of SREBP-
1c gene in hepatocytes as well as in the adipose and muscle tissues.This stimulatory effect of insulin on SREBP-1c protein in hepato-
cytes appears to be mediated through activation of phosphatidylin-
ositol 3-kinase (PI3K). The data obtained through the conditional
expression of PKB in hepatoma cells further reveal that activation
of PKB is sufﬁcient to mimic the biological effect of insulin. This
suggests that the insulin-dependent up-regulation of SREBP-1c
expression is mediated via activation of PKB [21]. Moreover, insu-
lin can also activate the transcription by SREBP-1c promoter
through its combinatorial actions on the SRE, LXREs, Sp1 and NF-
Y elements [22]. In addition, insulin can diminish the function of
FoxO1, but not FoxO1-3A by its phosphorylation by Akt/PKB path-
way and subsequent nuclear exclusion. We examined a potential
role of insulin in the FoxO1-inﬂicted repression of SREBP-1c pro-
moter, and found that insulin is able to partially reverse the sup-
pressive effect of FoxO1-wt, but not of FoxO1-3A mutant (Fig. 6).
SREBP-1c involved in fatty acid in liver and is mainly regulated
at the transcriptional level. Some factors participate in regulation
transcription of SREBP-1c, including insulin, LXRa, nutrition state,
glucose and SREBPs [23]. The LXRE elements are crucial to LXRa
and insulin regulation the SREBP-1c transcription. In rat hepato-
cytes, insulin increases the steady-state levels of LXRa mRNA,
but not LXRa protein. Ectopic expression of LXRa stimulates the
SREBP-1c promoter and insulin further augments this effect upon
elevated LXRa. These suggest that the stimulatory effect of insulin
on the SREBP-1c promoter is not limited to increasing the expres-
sion of LXRa. Simultaneous mutation of both LXREs in the proxim-
ity of SREBP-1c promoter reduced the stimulatory effect of insulin
by about 57%, indicating that insulin stimulates SREBP-1c
Fig. 6. Effects of insulin on the repression of LXRa trans-activation by FoxO1.
HepG2 cells were co-transfected with pBP1c2600-Luc reporter (200 ng) and LXRa
expression (100 ng) constructs together with 100 ng plasmid expressing either
FoxO1-wt or FoxO1-3A. Cells were incubated in DMEM with 10% fetal bovine serum
for 24 h, then serum-starved for 3 h, and treated with insulin (100 nM) for 6 h.
*P < 0.05.
Fig. 7. Schematic illustration of FoxO1/LXRa-mediated and insulin-induced regu-
lation of the SREBP-1c promoter.
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pendent mechanisms [22]. Our results also revealed that FoxO1
inhibits the activity of SREBP-1c promoter mainly but not strictly
through LXRa, suggesting that the negative effect of FoxO1 on
the SREBP-1c promoter is dependent as well as independent of
LXRa. FoxO proteins also contribute to the regulation of metabo-
lism through their effects in the liver, muscle, adipose tissue and
pancreas. An important role of FoxO1 in the regulation of gluco-
neogenesis is supported by up-regulation some gluconeogenesis-
relative genes, such as G6Pase, PEPCK, IGFBP-1 [24]. However, little
is known regarding the effect of FoxO1 in lipid metabolism. Our
study further indicated that FoxO1 inhibits the LXRa-mediated ele-
vated transcription by SREBP-1c promoter and insulin reverses the
suppressive effect of FoxO1. The schematic illustration of insulin-
dependent regulation of the SREBP-1c promoter is shown in
Fig. 7. Together, these results indicated that FoxO1 plays an impor-
tant role in the regulation of SREBP-1c transcription.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2010.09.027.
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